Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats

G Di Chiara and A Imperato

Institute of Experimental Pharmacology and Toxicology, University of Cagliari, Italy.

We studied the effect of opiates acting preferentially on mu receptors, like morphine, methadone and fentanyl (mu agonists) and on kappa receptors, like U50,488, bremazocine and tifluadom (kappa agonists) on the release of dopamine (DA) and of its metabolites, dihydroxyphenylacetic acid and homovanillic acid, from the nucleus accumbens and from the dorsal caudate of freely moving rats using brain dialysis coupled to high-performance liquid chromatography with electrochemical detection. Spontaneous behavior was videotaped and analyzed by estimating the percentage of time spent by the animals in performing certain specific behavioral items. Mu agonists stimulated DA- release and metabolism in the accumbens at lower doses than in the caudate. Maximal stimulation of DA release did not exceed 100% except after high doses of methadone (10 mg/kg) which stimulated DA release in the accumbens by more than 300%, possibly as a result of hypoxia. Stimulation of DA release was associated to stimulation of behavior at low doses and to a biphasic inhibitory-stimulatory syndrome after higher doses of the opiates. Pretreatment with low doses of naloxone (0.1 mg/kg s.c.) or with the irreversible mu antagonist beta- funaltrexamine (10 nmol i.c.v.) increased the ED50 for the stimulation of DA release by the three opiates. In contrast with mu agonists, agonists of kappa receptors like U50,488, bremazocine and tifluadom decreased DA release in the accumbens and in the caudate and reduced motor activity. These effects were antagonized only by rather high doses of naloxone (2.5 mg/kg s.c.) and were not affected by pretreatment with beta-funaltrexamine (10 nmol i.c.v.).(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 244, Issue 3, pp. 1067-1080, 03/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				J. Fichna, A. Janecka, J. Costentin, and J.-C. Do Rego The Endomorphin System and Its Evolving Neurophysiological Role Pharmacol. Rev., March 1, 2007; 59(1): 88 - 123. [Abstract] [Full Text] [PDF]

				C. P. Ford, M. J. Beckstead, and J. T. Williams Kappa Opioid Inhibition of Somatodendritic Dopamine Inhibitory Postsynaptic Currents J Neurophysiol, January 1, 2007; 97(1): 883 - 891. [Abstract] [Full Text] [PDF]

				A. Contarino and F. Papaleo The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal PNAS, December 20, 2005; 102(51): 18649 - 18654. [Abstract] [Full Text] [PDF]

				M. J. Kreek, G. Bart, C. Lilly, K. S. Laforge, and D. A. Nielsen Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments Pharmacol. Rev., March 1, 2005; 57(1): 1 - 26. [Abstract] [Full Text] [PDF]

				K. A. Leite-Morris, E. Y. Fukudome, M. H. Shoeb, and G. B. Kaplan GABAB Receptor Activation in the Ventral Tegmental Area Inhibits the Acquisition and Expression of Opiate-Induced Motor Sensitization J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 667 - 678. [Abstract] [Full Text] [PDF]

				L. L. Peoples and D. Cavanaugh Differential Changes in Signal and Background Firing of Accumbal Neurons During Cocaine Self-Administration J Neurophysiol, August 1, 2003; 90(2): 993 - 1010. [Abstract] [Full Text] [PDF]

				G. Bart, L. Borg, J. H. Schluger, M. Green, A. Ho, and M. J. Kreek Suppressed Prolactin Response to Dynorphin A1-13 in Methadone-Maintained Versus Control Subjects J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 581 - 587. [Abstract] [Full Text] [PDF]

				M. Solinas, L. V. Panlilio, K. Antoniou, L. A. Pappas, and S. R. Goldberg The Cannabinoid CB1 Antagonist N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) Differentially Alters the Reinforcing Effects of Heroin under Continuous Reinforcement, Fixed Ratio, and Progressive Ratio Schedules of Drug Self-Administration in Rats J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 93 - 102. [Abstract] [Full Text] [PDF]

				Z.-X. Xi and E. A. Stein GABAergic MECHANISMS OF OPIATE REINFORCEMENT Alcohol Alcohol., September 1, 2002; 37(5): 485 - 494. [Abstract] [Full Text] [PDF]

				K. P. Cosgrove and M. E. Carroll Effects of Bremazocine on Self-Administration of Smoked Cocaine Base and Orally Delivered Ethanol, Phencyclidine, Saccharin, and Food in Rhesus Monkeys: A Behavioral Economic Analysis J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 993 - 1002. [Abstract] [Full Text] [PDF]

				C. A. Schad, J. B. Justice Jr., and S. G. Holtzman Endogenous Opioids in Dopaminergic Cell Body Regions Modulate Amphetamine-Induced Increases in Extracellular Dopamine Levels in the Terminal Regions J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 932 - 938. [Abstract] [Full Text] [PDF]

				S. L. Walsh, B. Geter-Douglas, E. C. Strain, and G. E. Bigelow Enadoline and Butorphanol: Evaluation of kappa -Agonists on Cocaine Pharmacodynamics and Cocaine Self-Administration in Humans J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 147 - 158. [Abstract] [Full Text] [PDF]

				A. C. Thompson, A. Zapata, J. B. Justice Jr, R. A. Vaughan, L. G. Sharpe, and T. S. Shippenberg {kappa}-Opioid Receptor Activation Modifies Dopamine Uptake in the Nucleus Accumbens and Opposes the Effects of Cocaine J. Neurosci., December 15, 2000; 20(24): 9333 - 9340. [Abstract] [Full Text] [PDF]

				P. Brown and M. E. Molliver Dual Serotonin (5-HT) Projections to the Nucleus Accumbens Core and Shell: Relation of the 5-HT Transporter to Amphetamine-Induced Neurotoxicity J. Neurosci., March 1, 2000; 20(5): 1952 - 1963. [Abstract] [Full Text] [PDF]

				D. M. Platt, D. M. Grech, J. K. Rowlett, and R. D. Spealman Discriminative Stimulus Effects of Morphine in Squirrel Monkeys: Stimulants, Opioids, and Stimulant-Opioid Combinations J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1092 - 1100. [Abstract] [Full Text]

				Z.-B. You, M. Herrera-Marschitz, and L. Terenius Modulation of Neurotransmitter Release in the Basal Ganglia of the Rat Brain by Dynorphin Peptides J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1307 - 1315. [Abstract] [Full Text]

				Z.-X. Xi and E. A. Stein Baclofen Inhibits Heroin Self-Administration Behavior and Mesolimbic Dopamine Release J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1369 - 1374. [Abstract] [Full Text]

				G. Torres and J. M. Horowitz Drugs of Abuse and Brain Gene Expression Psychosom Med, September 1, 1999; 61(5): 630 - 650. [Abstract] [Full Text] [PDF]

				J. M. van Ree, M. A. F. M. Gerrits, and L. J. M. J. Vanderschuren Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine Pharmacol. Rev., June 1, 1999; 51(2): 341 - 396. [Abstract] [Full Text] [PDF]

				W. A. Carlezon Jr., J. Thome, V. G. Olson, S. B. Lane-Ladd, E. S. Brodkin, N. Hiroi, R. S. Duman, R. L. Neve, and E. J. Nestler Regulation of Cocaine Reward by CREB Science, December 18, 1998; 282(5397): 2272 - 2275. [Abstract] [Full Text]

				N. K. Mello and S. S. Negus Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 812 - 824. [Abstract] [Full Text]

				M. Marinelli, B. Aouizerate, M. Barrot, M. Le Moal, and P. V. Piazza Dopamine-dependent responses to morphine depend on glucocorticoid receptors PNAS, June 23, 1998; 95(13): 7742 - 7747. [Abstract] [Full Text] [PDF]

				G. Di Chiara A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use J Psychopharmacol, January 1, 1998; 12(1): 54 - 67. [Abstract] [PDF]

				Z.-X. Xi, S. A. Fuller, and E. A. Stein Dopamine Release in the Nucleus Accumbens during Heroin Self-Administration Is Modulated by Kappa Opioid Receptors: An In Vivo Fast-Cyclic Voltammetry Study J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 151 - 161. [Abstract] [Full Text]

				J. K. Staley, R. B. Rothman, K. C. Rice, J. Partilla, and D. C. Mash kappa 2 Opioid Receptors in Limbic Areas of the Human Brain Are Upregulated by Cocaine in Fatal Overdose Victims J. Neurosci., November 1, 1997; 17(21): 8225 - 8233. [Abstract] [Full Text] [PDF]

				B. Bontempi and F. R. Sharp Systemic Morphine-Induced Fos Protein in the Rat Striatum and Nucleus Accumbens Is Regulated by µ Opioid Receptors in the Substantia Nigra and Ventral Tegmental Area J. Neurosci., November 1, 1997; 17(21): 8596 - 8612. [Abstract] [Full Text] [PDF]

				H. L. Kimmel and S. G. Holtzman Mu Opioid Agonists Potentiate Amphetamine- and Cocaine-Induced Rotational Behavior in the Rat J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 734 - 746. [Abstract] [Full Text]

				S. S. Negus, N. K. Mello, P. S. Portoghese, and C.-E. Lin Effects of Kappa Opioids on Cocaine Self-Administration by Rhesus Monkeys J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 44 - 55. [Abstract] [Full Text]

				N. Mello, J. Mendelson, M. Bree, and S. Lukas Buprenorphine suppresses cocaine self-administration by rhesus monkeys Science, August 25, 1989; 245(4920): 859 - 862. [Abstract] [PDF]